Cuiling Qi

195# Dongfeng West Road
Guangzhou, 510182, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Protective Effects of Astragalin Against Acute Ultraviolet B-Induced Photodamage in HaCaT Cells and Mouse Skin.

Protective Effects of Astragalin Against Acute Ultraviolet B-Induced Photodamage in HaCaT Cells and Mouse Skin.

Journal: International journal of molecular sciences

Published: March 18, 2026

Serum amyloid P component suppresses melanoma growth and metastasis by inhibiting CCL1 secretion from macrophages.

Serum amyloid P component suppresses melanoma growth and metastasis by inhibiting CCL1 secretion from macrophages.

Journal: American journal of cancer research

Published: December 22, 2025

DPPA inhibits melanoma by targeting angiogenesis through activating autocrine IFN-γ-CXCL9/10/11-CXCR3 axis in vascular endothelial cells.

DPPA inhibits melanoma by targeting angiogenesis through activating autocrine IFN-γ-CXCL9/10/11-CXCR3 axis in vascular endothelial cells.

Journal: iScience

Published: July 24, 2025

A novel oridonin analogue, CYD0682, suppresses breast cancer growth, angiogenesis, and metastasis by inhibiting the ANGPTL4/MAPK signaling axis.

A novel oridonin analogue, CYD0682, suppresses breast cancer growth, angiogenesis, and metastasis by inhibiting the ANGPTL4/MAPK signaling axis.

Journal: Genes & diseases

Published: July 24, 2024

EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancer.

EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancer.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: November 21, 2023

SAP deletion promotes malignant insulinoma progression by inducing CXCL12 secretion from CAFs via the CXCR4/p38/ERK signalling pathway.

SAP deletion promotes malignant insulinoma progression by inducing CXCL12 secretion from CAFs via the CXCR4/p38/ERK signalling pathway.

Journal: Journal of cellular and molecular medicine

Published: November 10, 2023

CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth.

CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth.

Journal: BMC cancer

Published: November 24, 2022

NF-κB Activator 1 downregulation in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer.

NF-κB Activator 1 downregulation in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer.

Journal: BMC medicine

Published: June 22, 2022

1H-NMR based metabolic study of MMTV-PyMT mice along with pathological progress to screen biomarkers for the early diagnosis of breast cancer.

1H-NMR based metabolic study of MMTV-PyMT mice along with pathological progress to screen biomarkers for the early diagnosis of breast cancer.

Journal: Molecular omics

Published: December 17, 2021

Decylubiquinone Inhibits Colorectal Cancer Growth Through Upregulating Sirtuin2.

Decylubiquinone Inhibits Colorectal Cancer Growth Through Upregulating Sirtuin2.

Journal: Frontiers in pharmacology

Published: October 29, 2021

LncRNA Gas5 regulates Fn1 deposition via Creb5 in renal fibrosis.

LncRNA Gas5 regulates Fn1 deposition via Creb5 in renal fibrosis.

Journal: Epigenomics

Published: April 20, 2021

Glipizide Combined with ANP Suppresses Breast Cancer Growth and Metastasis by Inhibiting Angiogenesis through VEGF/VEGFR2 Signaling.

Glipizide Combined with ANP Suppresses Breast Cancer Growth and Metastasis by Inhibiting Angiogenesis through VEGF/VEGFR2 Signaling.

Journal: Anti-cancer agents in medicinal chemistry

Published: February 17, 2021

Showing 1-12 of 36

Last Updated: 09/26/2026